In a first‑trimester pregnant woman with a focal uterine contraction on ultrasound but no vaginal bleeding, cervical shortening, or open cervical os, is progesterone therapy (Duphaston – dydrogesterone) indicated? | Rounds In a first‑trimester pregnant woman with a focal uterine contraction on ultrasound but no vaginal bleeding, cervical shortening, or open cervical os, is progesterone therapy (Duphaston – dydrogesterone) indicated? | Rounds
Loading...

In a first‑trimester pregnant woman with a focal uterine contraction on ultrasound but no vaginal bleeding, cervical shortening, or open cervical os, is progesterone therapy (Duphaston – dydrogesterone) indicated?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Progesterone Therapy Indications in First-Trimester Suspected Threatened Miscarriage

Progesterone therapy is recommended only for women with early pregnancy bleeding plus a history of miscarriage. [1]

In the absence of vaginal bleeding, progesterone therapy is not recommended for prevention of miscarriage based on current guideline criteria. [1]

Medication Selection Algorithm

Progestogen therapy for preventing early pregnancy loss is indicated only when both criteria are present: [1]

  • Early pregnancy bleeding in the current pregnancy. [1]
  • A previous history of miscarriage. [1]

Dydrogesterone (Duphaston) use for this indication is encompassed within guideline discussions of progesterone/progestogens for threatened miscarriage only when bleeding and miscarriage history criteria are met. [1]

Key Evidence Supporting This Recommendation

NICE guideline evidence review found no benefit of progesterone in women with early pregnancy bleeding but no previous miscarriage. [1]

NICE guideline evidence review also found no benefit of progesterone in women with previous miscarriage but no early pregnancy bleeding in the current pregnancy. [1]

Monotherapy vs Combination Therapy

Progesterone/progestogen use for threatened miscarriage prevention is not indicated in the scenario of no vaginal bleeding, so escalation to any combination regimen is not applicable. [1]

Important Clarifications and Nuances

Focal uterine contractions on ultrasound without vaginal bleeding do not meet the guideline-defined criterion of early pregnancy bleeding requiring progesterone therapy. [1]

Progesterone recommendations are limited to the threatened miscarriage context and are not applied to other clinical presentations lacking the guideline-defined bleeding history profile. [1]

Treatment Initiation Thresholds

Progesterone therapy should not be initiated when the current pregnancy has no vaginal bleeding. [1]

Progesterone therapy should not be initiated when there is no history of previous miscarriage, even if early pregnancy bleeding is present. [1]

Common Pitfalls to Avoid

A common pitfall is using progesterone in women with suspected threatened miscarriage who have no vaginal bleeding. [1]

Another pitfall is using progesterone when early pregnancy bleeding is present but there is no prior miscarriage history. [1]

Target Outcomes of Therapy

Guideline-supported progesterone use targets reduction of miscarriage risk in women who meet both eligibility criteria of early pregnancy bleeding and previous miscarriage history. [1]

In women without these criteria, the risk reduction benefit is not supported by guideline evidence. [1]

Related Questions